IntraCellular Therapies (ITCI)
(Delayed Data from NSDQ)
$76.48 USD
+1.62 (2.16%)
Updated Jul 22, 2024 04:00 PM ET
3-Hold of 5 3
F Value D Growth F Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/01/2024
Time: -- |
6/2024 | $-0.19 | 11.83% |
Earnings Summary
For their last quarter, IntraCellular Therapies (ITCI) reported earnings of -$0.16 per share, beating the Zacks Consensus Estimate of $-0.31 per share. This reflects a positive earnings surprise of 48.39%. Look out for ITCI's next earnings release expected on August 01, 2024. For the next earning release, we expect the company to report earnings of -$0.19 per share, reflecting a year-over-year increase of 57.78%.
Earnings History
Price & Consensus
Zacks News for ITCI
Wall Street Analysts See a 30.14% Upside in Intra-Cellular (ITCI): Can the Stock Really Move This High?
ITCI: What are Zacks experts saying now?
Zacks Private Portfolio Services